StockIQStockIQ.tech

IQVIA Holdings Inc. (IQV) Stock Analysis

--

Free AI-powered analysis and research for IQVIA Holdings Inc. stock

Sector: Healthcare

IQV snapshot

Data as of 3 Nov 2026 close. Updated daily.

Last close
261.80 USD (+1.30%)
52-week range
154.50 – 284.50
Position in range
83%
1-year change
+22.4%
Market cap (USD)
$43.1B
P/E (trailing)
32.5
RSI (14-day)
45
vs 200-day average
+24.8%
MACD
Below signal line
StockIQ score: 28/100 · Negative signals

IQVIA Holdings Inc. scores 28/100 on StockIQ's model, which reads as negative signals overall. The price is above its 200-day average and at 83% of its 52-week range, up 22.4% over the past year. Latest reported figures show a profit margin of 8.1%, return on equity of 21.4% and revenue growth of +8.0%.

What is driving the score
  • RSI Neutral: +5
  • Downtrend: -4
  • MACD Bearish: -8
  • High P/E (32.5): -10
  • High Debt (2.40 D/E): -10
  • Low Liquidity (0.83 Current Ratio): -10
  • Excellent ROE (21.4%): +8
  • High P/B (6.61): -5
  • Strong Long-term Uptrend: +8
  • Healthy Momentum (+22.4% over 1 year): +7
  • Low Volume (0.3x): -3

Automated, general information only – not financial advice. Scores can be wrong. How the score works

Full IQV report

IQVIA Holdings Inc. (IQV) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze IQV Now β†’

πŸ“° Latest Update

IQV Q3 deep dive: AI adoption and clinical momentum drive growth, guidance raised

IQV reported strong growth in Q3, driven by increased adoption of AI technologies and momentum in clinical services. The company raised its guidance for the year, indicating confidence in its ongoing performance and market position. This positive outlook is significant for investors, as it suggests robust demand for IQV's offerings and potential for continued revenue growth.

Read full article β†’

History

People also watch

TMO
Thermo Fisher Scientific Inc.
--
CI
Cigna Group
--
BMY
Bristol-Myers Squibb Company
--
SMMT
Summit Therapeutics Inc.
--
LFST
LifeStance Health Group, Inc.
--